Avelumab for Advanced Merkel Cell Carcinoma: Global Real-World Data on Patient Response and Survival.
Rishabh LohrayKritin K VermaLeo L WangDylan HaynesDaniel J LewisPublished in: Pragmatic and observational research (2023)
The use of avelumab as a safe and effective treatment option for advanced MCC is supported by real-world data, although additional study is required to assess long-term efficacy and safety outcomes.